| Latest Scolr Pharma News Headlines | | Date | Time | Source | | | 11/12/2008 | 9:00AM | PRNUS | SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition
BOTHELL, Wash., Nov. 12 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) announced today that representatives from its research and development team will be attending the 2008 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting to be held November, 16-20, 2008 at the Georgia World Congress... More...>> |
| 11/07/2008 | 8:30AM | PRNUS | SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
Pivotal Phase III Trial Primary Endpoints Achieved for SCOLR's 12-Hour Ibuprofen
BOTHELL, Wash., Nov. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) today reported financial results for the three and nine months ended September 30, 2008. The Company will host a live conference call today, November 7, 2008... More...>> |
| 10/31/2008 | 10:00AM | PRNUS | SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
BOTHELL, Wash., Oct. 31 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) today announced plans to release third quarter 2008 financial results on Friday, November 7, 2008, at 8:30 a.m. Eastern. Daniel O. Wilds, President and CEO of SCOLR Pharma, will host the conference call at 11:30 a.m. Eastern, to discuss... More...>> |
| 09/26/2008 | 9:00AM | PRNUS | SCOLR Pharma's ANDA for 12-Hour CDT-Based Pseudoephedrine Accepted for Review by U.S. FDA
BOTHELL, Wash., Sept. 26 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) announced today that the United States Food and Drug Administration ("FDA") has accepted for review the Company's Abbreviated New Drug Application (ANDA) for a 120 milligram 12-hour pseudoephedrine tablet based on the Company's patented... More...>> |
| 09/24/2008 | 8:30AM | PRNUS | SCOLR Pharma, Inc. Receives $3.1 Million Lease Termination Payment
Company has relocated its headquarters to new facility in Bothell, Washington
BELLEVUE, Wash., Sept. 24 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) today announced that it has received the remaining $3.1 million of the total $4.1 million payment, pursuant to the terms of the lease termination agreement with... More...>> |
| 08/07/2008 | 8:30AM | PRNUS | SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
BELLEVUE, Wash., Aug. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) today reported financial results for the three and six months ended June 30, 2008. The Company will host a live conference call today, August 7, 2008, at 11:30 a.m. (Eastern Daylight Time).
Daniel O. Wilds, SCOLR Pharma's President and... More...>> |
| 08/06/2008 | 9:00AM | PRNUS | SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
BELLEVUE, Wash., Aug. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) announced today that it has submitted to the Food and Drug Administration an Abbreviated New Drug Application (ANDA) for a 120 milligram 12-hour pseudoephedrine tablet based on the Company's patented Controlled Delivery Technology (CDT(R... More...>> |
| 07/29/2008 | 11:55AM | PRNUS | SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
BELLEVUE, Wash., July 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) today announced plans to release second quarter 2008 financial results on Thursday, August 7, 2008, at 8:30 a.m. Eastern. Daniel O. Wilds, President and CEO of SCOLR Pharma, will host a conference call at 11:30 a.m. Eastern, to discuss... More...>> |
| 01/22/2007 | 9:00AM | PRNUS | American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007
Leading Healthcare Companies Scheduled to Present
NEW YORK, Jan. 22 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today announced that it will host its First Annual Healthcare Investor Conference in Boston on Thursday, February 8, 2007. Companies scheduled to present include leading Amex-listed healthcare... More...>> |
| 10/20/2005 | 4:36PM | PRNUS | SCOLR Pharma and Perrigo Announce Strategic Alliance to Manufacture and Market CDT(R) Nutritional Products
BELLEVUE, Wash. and ALLEGAN, Mich., Oct. 20 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX:DDD) and Perrigo Company (NASDAQ:PRGO)(TASE:PRGO) announced today that they entered into an agreement whereby Perrigo will manufacture and market certain sustained release nutritional products based on SCOLR Pharma's proprietary... More...>> |
|